TransEnterix, Inc. announced that Brett Farabaugh has joined as interim Chief Financial Officer, effective January 2, 2020, replacing Joe Slattery who retired December 31, 2019. Mr. Farabaugh has served as CFO of Tryton Medical, Inc. since August 2008, and as CEO of Tryton Medical since August 2019. Prior to Tryton Medical, Mr. Farabaugh served as CFO of Strikeiron, Inc., from 2006-2008, as Vice President of Finance for Icoria, Inc. (formerly Paradigm Genetics, Inc.), from 2004-2006. Mr. Farabaugh will serve as Interim Chief Financial Officer until April 30, 2020.